Kaufman PA - Search Results

1

Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial.

Pernas S, Martin M, Kaufman PA, Gil-Martin M, Gomez Pardo P, Lopez-Tarruella S, Manso L, Ciruelos E, Perez-Fidalgo JA, Hernando C, Ademuyiwa FO, Weilbaecher K, Mayer I, Pluard TJ, Martinez Garcia M, Vahdat L, Perez-Garcia J, Wach A, Barker D, Fung S, Romagnoli B, Cortes J. Pernas S, et al. Among authors: kaufman pa. Lancet Oncol. 2018 Jun;19(6):812-824. doi: 10.1016/S1470-2045(18)30147-5. Epub 2018 Apr 26. Lancet Oncol. 2018. PMID: 29706375 Clinical Trial.

2

Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu.

Valone FH, Kaufman PA, Guyre PM, Lewis LD, Memoli V, Deo Y, Graziano R, Fisher JL, Meyer L, Mrozek-Orlowski M, et al. Valone FH, et al. Among authors: kaufman pa. J Clin Oncol. 1995 Sep;13(9):2281-92. doi: 10.1200/JCO.1995.13.9.2281. J Clin Oncol. 1995. PMID: 7545221 Clinical Trial.

3

Phase II trial of tamoxifen, etoposide, mitoxantrone, and cisplatin in patients with metastatic breast carcinoma.

Conzen SD, Kaufman PA, Arvizu C, LeMarbre P, Maurer LH, Mott LA, Mills LE. Conzen SD, et al. Among authors: kaufman pa. Cancer. 1996 Nov 1;78(9):1906-11. doi: 10.1002/(sici)1097-0142(19961101)78:9<1906::aid-cncr10>3.0.co;2-1. Cancer. 1996. PMID: 8909310 Clinical Trial.

4

Paclitaxel and anthracycline combination chemotherapy for metastatic breast cancer.

Kaufman PA. Kaufman PA. Semin Oncol. 1999 Jun;26(3 Suppl 8):39-46. Semin Oncol. 1999. PMID: 10403473 Review.

5

Phase II multicenter study of larotaxel (XRP9881), a novel taxoid, in patients with metastatic breast cancer who previously received taxane-based therapy.

Diéras V, Limentani S, Romieu G, Tubiana-Hulin M, Lortholary A, Kaufman P, Girre V, Besenval M, Valero V. Diéras V, et al. Ann Oncol. 2008 Jul;19(7):1255-1260. doi: 10.1093/annonc/mdn060. Epub 2008 Apr 1. Ann Oncol. 2008. PMID: 18381372 Free article. Clinical Trial.

6

Phase III trials of eribulin mesylate (E7389) in extensively pretreated patients with locally recurrent or metastatic breast cancer.

Twelves C, Cortes J, Vahdat LT, Wanders J, Akerele C, Kaufman PA. Twelves C, et al. Among authors: kaufman pa. Clin Breast Cancer. 2010 Apr;10(2):160-3. doi: 10.3816/CBC.2010.n.023. Clin Breast Cancer. 2010. PMID: 20299316 Clinical Trial.

7

Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve.

Ahles TA, Saykin AJ, McDonald BC, Li Y, Furstenberg CT, Hanscom BS, Mulrooney TJ, Schwartz GN, Kaufman PA. Ahles TA, et al. Among authors: kaufman pa. J Clin Oncol. 2010 Oct 10;28(29):4434-40. doi: 10.1200/JCO.2009.27.0827. Epub 2010 Sep 13. J Clin Oncol. 2010. PMID: 20837957 Free PMC article. Clinical Trial.

8

Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.

Baselga J, Cortés J, Kim SB, Im SA, Hegg R, Im YH, Roman L, Pedrini JL, Pienkowski T, Knott A, Clark E, Benyunes MC, Ross G, Swain SM; CLEOPATRA Study Group. Baselga J, et al. N Engl J Med. 2012 Jan 12;366(2):109-19. doi: 10.1056/NEJMoa1113216. Epub 2011 Dec 7. N Engl J Med. 2012. PMID: 22149875 Free PMC article. Clinical Trial.

9

Treatment patterns and clinical outcomes in elderly patients with HER2-positive metastatic breast cancer from the registHER observational study.

Kaufman PA, Brufsky AM, Mayer M, Rugo HS, Tripathy D, Yood MU, Feng S, Wang LI, Quah CS, Yardley DA. Kaufman PA, et al. Breast Cancer Res Treat. 2012 Oct;135(3):875-83. doi: 10.1007/s10549-012-2209-z. Epub 2012 Aug 26. Breast Cancer Res Treat. 2012. PMID: 22923238 Free PMC article.

10

Ganitumab with either exemestane or fulvestrant for postmenopausal women with advanced, hormone-receptor-positive breast cancer: a randomised, controlled, double-blind, phase 2 trial.

Robertson JF, Ferrero JM, Bourgeois H, Kennecke H, de Boer RH, Jacot W, McGreivy J, Suzuki S, Zhu M, McCaffery I, Loh E, Gansert JL, Kaufman PA. Robertson JF, et al. Among authors: kaufman pa. Lancet Oncol. 2013 Mar;14(3):228-35. doi: 10.1016/S1470-2045(13)70026-3. Epub 2013 Feb 13. Lancet Oncol. 2013. PMID: 23414585 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

139 results

Search Page